Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
RESEARCH TOOLSreports
Holding IKT?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | $ 116.41K |
| Gross Profit | - | - | - | - | $ 116.41K |
| EBIT | $ -5.83M | $ -5.05M | $ -4.79M | $ -4.77M | $ -6.20M |
| EBITDA | $ -5.82M | $ -5.04M | $ -4.78M | $ -4.76M | $ -6.04M |
| Net Income Common Stockholders | $ -5.78M | $ -4.96M | $ -4.65M | $ -4.60M | $ -5.78M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 3.24M | $ 7.94M | $ 9.75M | $ 16.83M | $ 20.94M |
| Total Assets | $ 4.38M | $ 8.83M | $ 11.07M | $ 17.88M | $ 22.35M |
| Total Debt | $ 145.21K | $ 177.83K | $ 209.49K | $ 270.04K | $ 297.94K |
| Net Debt | $ -3.10M | $ -7.76M | $ -9.54M | $ -16.56M | $ -20.64M |
| Total Liabilities | $ 4.91M | $ 3.73M | $ 4.29M | $ 2.86M | $ 2.88M |
| Stockholders Equity | $ -530.59K | $ 5.10M | $ 6.78M | $ 15.02M | $ 19.46M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.88M | $ -5.05M | $ -3.87M | $ -4.11M | $ -4.58M |
| Operating Cash Flow | $ -4.88M | $ -5.05M | $ -3.87M | $ -4.11M | $ -4.57M |
| Investing Cash Flow | $ 2.53M | $ 2.54M | $ -3.31M | $ 17.06M | $ 2.55M |
| Financing Cash Flow | $ 181.95K | $ 3.24M | $ 367.00K | $ 70.00 | $ -35.99K |